Related Experiment Video
Updated: Jul 1, 2026
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Beta-cell failure as a complication of diabetes
K J Chang-Chen1, R Mullur, E Bernal-Mizrachi
1Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA.
Reviews in Endocrine & Metabolic Disorders
|September 9, 2008
Summary
Type 2 diabetes involves pancreatic beta-cell failure due to insulin resistance. Understanding mechanisms like glucotoxicity and lipotoxicity is key to finding new therapeutic targets for this complex disease.
Area of Science:
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and progressive pancreatic beta-cell dysfunction.
- Beta-cells initially compensate for insulin resistance by increasing mass and function, but persistent nutrient excess leads to failure.
Purpose of the Study:
- To review the regulation of beta-cell mass under normal conditions.
- To elucidate the mechanisms underlying beta-cell failure in T2DM, including glucotoxicity, lipotoxicity, and endoplasmic reticulum stress.
Main Methods:
- This is a review article, synthesizing existing research on beta-cell biology and T2DM pathogenesis.
- Key mechanisms discussed include reactive oxygen species generation, metabolic pathway alterations, and intracellular calcium changes.
Main Results:
- Persistent hyperglycemia and elevated free fatty acids impair beta-cell function through various detrimental pathways.
- These pathways lead to reduced insulin secretion, decreased insulin gene expression, and ultimately beta-cell apoptosis.
Conclusions:
- Beta-cell failure is a central event in T2DM development, driven by factors like glucotoxicity and lipotoxicity.
- Further research into these mechanisms may reveal novel therapeutic targets for T2DM.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...